International law firm Pinsent Masons has boosted its Life Sciences group with the appointment of a four-strong Partner team.
The team of Paul Ranson, Allistair Booth, Stuart Richards and Charles Waddell – has a market-leading reputation for life sciences IP, regulatory and transactional work.
They join a formidable Life Sciences team at Pinsent Masons, led by life sciences patent litigator Clare Tunstall, and complete the firm’s full-service offering across the sector.
Paul Ranson is a well-known figure in the Life Sciences world having previously headed the Healthcare group at Simmons & Simmons.
Allistair Booth and Stuart Richards work across corporate, commercial and non-contentious IP matters in the sector.
Charles Waddell is a well known corporate finance specialist in the sector. His primary focus is advising in the biotechnology and medtech sectors on equity raisings, mergers and acquisitions and other corporate transactions.. The team, which is ranked in the top tier of Life Sciences advisers by leading independent legal directories Chambers and Legal 500, has a strong client base of pharmaceutical, drug delivery, biotech and, medtech companies.
They arrive from the London office of Canadian firm Fasken Martineau and will bring the total number of lateral hires announced by Pinsent Masons in 2013 to seven.
David Ryan, Managing Partner of Pinsent Masons, says:
“We have started the year strongly, with significant hires into those areas where we see the greatest opportunity for growth domestically and internationally, and will continue to make investments in line with our sector-focused strategy.
“These appointments ensure that Pinsent Masons’ offering in the Life Sciences sector is unrivalled, providing in depth expertise on business critical issues as well and the ability to deploy ‘go to’ partner specialists on all business as usual areas.We are therefore delighted that Paul and his colleagues are joining us.”
